TTOO - T2 BiosystemsAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $1.78 | Open | $1.79 |
| Volume | 7.1M | Market Cap | 263.36M |
| Yield | Last Dividend |
| Why BeiGene, T2 Biosystems And Amneal Ar... | 01/12/21 |
| BeiGene (NASDAQ: BGNE ) shares are trading higher ??? Full story available on Benzinga.com | |
| TTOO Stock: 10 Things to Know About T2 B... | 01/12/21 |
| T2 Biosystems (TTOO) stock is on the rise Tuesday following positive news concerning testing for new strains of the novel coronavirus. | |
| TTOO Stock: T2 Biosystems Climbs on COVI... | 01/12/21 |
| TTOO stock is making a run for the top in the market this morning, squeezing the shorts after announcing COVID-19 news. | |
| The Daily Biotech Pulse: GSK, Vir To Sta... | 01/12/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X... | |
| T2 Biosystems Does Earnings Surprise His... | 11/04/20 |
| T2 Biosystems announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| T2 Biosystems (NASDAQ:TTOO) Stock Price ... | 10/20/20 |
| T2 Biosystems Inc (NASDAQ:TTOO) shares passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $1.... | |
| Sepsis Diagnostics Market Worth USD 700 ... | 10/14/20 |
| According to the new market research report "Sepsis Diagnostics Market by Technology (Microbiology, PCR, Microarray, Immunoassay, Biomarkers), Product... | |
| Global Sepsis Market 2020(Covid-19 Updat... | 10/12/20 |
| ???Global Sepsis Market???Industry Trends and Forecast to 2027??? focuses on the major drivers and restraints for the key players. These research repo... | |
| T2 Biosystems Announces Second Quarter 2... | 08/11/20 |
| LEXINGTON, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, to... | |
| Earnings Outlook for T2 Biosystems | 08/10/20 |
| T2 Biosystems (NASDAQ: TTOO) announces its next round of earnings this Tuesday, August 11. Here is Benzinga's everything-that-matters guide for this ?... | |
| T2 Biosystems to Report Second Quarter 2... | 07/28/20 |
| LEXINGTON, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens,??? | |
| T2 Biosystems Solidifies Its Position as... | 07/01/20 |
| No summary available. | |
| The Daily Biotech Pulse: T2 Biosystems L... | 07/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) ADC... | |
| T2 Biosystems Announces Changes to Board... | 06/15/20 |
| LEXINGTON, Mass., June 15, 2020 -- T2 Biosystems, Inc. , a leader in the rapid detection of sepsis-causing pathogens, today announced three new Board ... | |
| Are Options Traders Betting on a Big Mov... | 06/08/20 |
| Investors need to pay close attention to T2 Biosystems (TTOO) stock based on the movements in the options market lately. | |
| Has T2 Biosystems (TTOO) Outpaced Other ... | 06/05/20 |
| Is (TTOO) Outperforming Other Medical Stocks This Year? | |
| T2 Biosystems : Thinking about buying st... | 06/03/20 |
| NEW YORK, June 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APPS, MAT, TTOO, ALT, and MGI. ??? | June 3, 2020 | |
| The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
| Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... | |
| The Daily Biotech Pulse: Breakthrough De... | 03/06/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5... | |
| T2 Biosystems (NASDAQ:TTOO) Earns Buy Ra... | 11/18/19 |
| Canaccord Genuity restated their buy rating on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Wednesday morning, AnalystRatings.com rep... | |
| Analysts Estimate T2 Biosystems (TTOO) t... | 11/05/19 |
| T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared ... | |
| Earnings Preview: T2 Biosystems (TTOO) Q... | 10/31/19 |
| T2 Biosystems (TTOO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared ... | |
| T2 Biosystems (TTOO) Reports Q2 Loss, Mi... | 07/30/19 |
| T2 Biosystems (TTOO) delivered earnings and revenue surprises of -9.38% and -10.07%, respectively, for the quarter ended June 2019. Do the numbers hol... | |
| The Daily Biotech Pulse: Lilly Reports P... | 06/11/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 10) ... | |
| LB, NBR, UVV and WMS among midday movers | 05/23/19 |
| No summary available. | |
| Ekso Bionics and Tonix Pharmaceuticals a... | 05/23/19 |
| No summary available. | |
| WB, NTAP and HRL among premarket losers | 05/23/19 |
| No summary available. | |
| T2 Biosystems: Failed Product Launch And... | 05/23/19 |
| No summary available. | |
| Research From The 2019 ECCMID Conference... | 05/09/19 |
| No summary available. | |
| T2 Biosystems: Encouraging Q1 Report, Co... | 05/07/19 |
| No summary available. | |
| Strong Buy rating | 11/05/20 |
| SVB Leerink maintains Outperform rating and raises Price Target from $3.00 to $4.00 | |
| Buy rating | 11/05/20 |
| Canaccord Genuity maintains Buy rating and lowers Price Target from $4.00 to $3.50 | |
| Date | 2020-11-04 (AMC) | Est. (EPS/Rev.) | ($0.08)/ 4.98M |
| Actual (EPS/Rev.) | $-0.08/ $5.25 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| 2% Milking | The Grim Contango | 84.00 % | Subscribe |
| Tech Trades | Tech Trades | 81.00 % | Follow |
| Stocks and Options Elite | Calvin Moore | 75.00 % | Subscribe |
| Best Trading Ideas | Best Trading Ideas | 54.00 % | Follow |
| Small Cap Trader | James Bills | 52.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
